No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
ZBH250117C55000
- 0.00
- 0.000.00%
15min DelayClose Jan 10 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest55.00Strike Price0.00Turnover247.05%IV-47.39%PremiumJan 17, 2025Expiry Date49.54Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9814Delta0.0013Gamma2.10Leverage Ratio-0.1125Theta0.0097Rho2.06Eff Leverage0.0065Vega
Intraday
- 5D
- Daily
No Data
News
NeuroOne Expects Higher Fiscal Q1 Revenue -- Shares Up
Bernstein Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Cuts Target Price to $111
Bernstein Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Cuts Target Price to $122
Bernstein Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH)
RBC Capital Maintains Zimmer Biomet Holdings(ZBH.US) With Buy Rating, Maintains Target Price $130
Zimmer Biomet Holdings (ZBH) Receives a Buy From RBC Capital